Table 4.

Effects of BCACs on Serum Levels of Antioxidant Activity of Patients with OAG (BCACs, n=19 and Placebo Groups, n=19)

	Anti-oxidant activity (μmol/L)
Group	0 M	6 M	12 M	18 M	24 M
BCACs	0.204±0.042	0.203±0.048	0.197±0.058	0.194±0.061	0.203±0.055
Placebo	0.201±0.051	0.193±0.052	0.191±0.054	0.197±0.053	0.195±0.049

Mean±SD (all such values).

No statistical differences between groups (2-way repeated measures ANOVA) and intergroups (paired t-test) were observed.